dactinomycin and l-165041

dactinomycin has been researched along with l-165041 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jacobsson, A; Jörgensen, JA; Zadravec, D	1

Other Studies

1 other study(ies) available for dactinomycin and l-165041

Article	Year
Norepinephrine and rosiglitazone synergistically induce Elovl3 expression in brown adipocytes. American journal of physiology. Endocrinology and metabolism, 2007, Volume: 293, Issue:5 Topics: Acetyltransferases; Adipocytes; Adipose Tissue, Brown; Animals; Cell Proliferation; Cycloheximide; Dactinomycin; Drug Synergism; Fatty Acid Elongases; Gene Expression Regulation; Male; Membrane Proteins; Mice; Norepinephrine; Peroxisome Proliferators; Phenoxyacetates; PPAR gamma; Protein Synthesis Inhibitors; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Transcription, Genetic	2007

Article

Year

Norepinephrine and rosiglitazone synergistically induce Elovl3 expression in brown adipocytes.

American journal of physiology. Endocrinology and metabolism, 2007, Volume: 293, Issue:5

Topics: Acetyltransferases; Adipocytes; Adipose Tissue, Brown; Animals; Cell Proliferation; Cycloheximide; Dactinomycin; Drug Synergism; Fatty Acid Elongases; Gene Expression Regulation; Male; Membrane Proteins; Mice; Norepinephrine; Peroxisome Proliferators; Phenoxyacetates; PPAR gamma; Protein Synthesis Inhibitors; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Transcription, Genetic

2007